Suchergebnisse - "Haberman, Rebecca H"

PubPharm (32)

1

Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center

enthalten in: bioRxiv.org | 2024

von Haberman, R. | Um, S. | Catron, S. | +8

2

Psychosocial Factors Significantly Contribute to Joint Pain Persistence in Psoriatic Arthritis

enthalten in: The Journal of rheumatology | 2024

von Haberman, R. | Zhou, Y. | Catron, S. | +4

3

Racial and ethnic determinants of psoriatic arthritis phenotypes and disease activity

enthalten in: Rheumatology (Oxford, England) | 2024

von Haberman, R. | Ahmed, T. | Um, S. | +12

4

Paradoxical Effects of Depression on Psoriatic Arthritis Outcomes in a Combined Psoriasis-Psoriatic Arthritis Center

enthalten in: Journal of psoriasis and psoriatic arthritis | 2023

von Haberman, R. | Um, S. | Catron, S. | +8

5

Spatial transcriptomics stratifies psoriatic disease severity by emergent cellular ecosystems

enthalten in: Science immunology | 2023

von Castillo, R. | Sidhu, I. | Dolgalev, I. | +22

6

Alterations in the cutaneous microbiome of patients with psoriasis and psoriatic arthritis reveal similarities between non-lesional and lesional skin

enthalten in: Annals of the rheumatic diseases | 2023

von Boix-Amorós, A. | Badri, M. | Manasson, J. | +10

7

Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritis

enthalten in: Rheumatology (Oxford, England) | 2022

von Blank, R. | Haberman, R. | Qian, K. | +17

8

Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA) : protocol of a randomised, double-blind, placebo controlled multicentre trial

enthalten in: BMJ open | 2022

von Haberman, R. | MacFarlane, K. | Catron, S. | +21

ErratumIn: BMJ Open. 2023 Apr 6;13(4):e063650corr1. - PMID 37024259

9

Cardiovascular and Venous Thromboembolic Risk With Janus Kinase Inhibitors in Immune-Mediated Inflammatory Diseases : A Systematic Review and Meta-Analysis of Randomized Trials

enthalten in: ACR open rheumatology | 2022

von Maqsood, M. | Weber, B. | Haberman, R. | +3

10

Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City

enthalten in: The Lancet. Rheumatology | 2022

von Saxena, A. | Engel, A. | Banbury, B. | +14